Plain-English translation of NCT07620392 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a long-term follow-up study for people with rheumatoid arthritis who have already received in an earlier trial. Researchers want to continue tracking how safe and effective this medication is when people take it over many months. You would be continuing the same treatment you were already receiving.
Many people with rheumatoid arthritis do not respond well to the most common treatments available. This study is designed to gather more information about whether this medication can safely help people who have tried other options without success and to understand how well it works over the long term.
You likely qualify if…
You likely don't qualify if…
You would continue receiving the same medication as injections under your skin, just as you did in the previous trial. You would attend regular follow-up visits so doctors can monitor how you are responding and check for any side effects. The study is designed to gather safety and effectiveness information over an extended period of time.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States
Poland